Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Sales | 6,497 | 1,487 | 0 |
| Gross Profit | 6,497 | 1,487 | N/A |
| Operating Expenses | 81,181 | 53,537 | 34,794 |
| Operating Income | -74,684 | -52,050 | -34,794 |
| Other Income | 10,953 | 8,070 | 6,153 |
| Pre-tax Income | -63,731 | -43,980 | -28,641 |
| Net Income Continuous | -63,731 | -43,980 | -28,641 |
| Net Income | $-63,731 | $-43,980 | $-28,641 |
| EPS Basic Total Ops | -78.34 | -62.46 | -46.56 |
| EPS Basic Continuous Ops | -78.34 | -62.46 | -46.55 |
| EPS Diluted Total Ops | -78.34 | -62.46 | -46.56 |
| EPS Diluted Continuous Ops | -78.34 | -62.46 | -46.55 |
| EPS Diluted Before Non-Recurring Items | -78.34 | N/A | N/A |
| EBITDA(a) | $-76,979 | $-54,556 | $-36,820 |